Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Port

Showing results (21-30 of 47) with videos related to

Pageof 5
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 15, 2012
18F-FDG PET as a surrogate biomarker in non-small cell lung cancer treated with erlotinib: newly identified lesions are more informative than standardized uptake valueThomas Bengtsson, Rodney J Hicks, Amy Peterson, et al.
Oncology|November 1, 1994
Influence of tetrachlorodecaoxide (Ryoxon) on the development of leukemia after total-body gamma-irradiationS R Kempf, K Blaszkiewitz, R E Port, et al.
American Journal of Medical Genetics. Part A|November 24, 2004
Changing profile of couples seeking genetic counseling for consanguinity in AustraliaKatrina E Port, Helen Mountain, John Nelson, et al.
EJNMMI Research|February 3, 2012
Quantitation of glucose uptake in tumors by dynamic FDG-PET has less glucose bias and lower variability when adjusted for partial saturation of glucose transportSimon-Peter Williams, Judith E Flores-Mercado, Ruediger E Port, et al.
The British Journal of Surgery|August 12, 2008
Study of quadrant high-dose intraoperative radiation therapy for early-stage breast cancerV Sacchini, K Beal, J Goldberg, et al.
Cancer Research|March 15, 1988
Metabolites of 5-fluorouracil in plasma and urine, as monitored by 19F nuclear magnetic resonance spectroscopy, for patients receiving chemotherapy with or without methotrexate pretreatmentW E Hull, R E Port, R Herrmann, et al.
Clinical Pharmacology and Therapeutics|March 1, 1995
A population model for the leukopenic effect of etoposideM O Karlsson, R E Port, M J Ratain, et al.
Journal of Magnetic Resonance (San Diego, Calif. : 1997)|July 9, 1998
Monitoring local disposition kinetics of carboplatin in vivo after subcutaneous injection in rats by means of 195Pt NMRM Becker, R E Port, H J Zabel, et al.
Clinical Pharmacokinetics|January 13, 2004
Recombinant human erythropoietin for the treatment of renal anaemia in children: no justification for bodyweight-adjusted dosageRuediger E Port, Daniela Kiepe, Michael Van Guilder, et al.
Journal of Magnetic Resonance Imaging : JMRI|October 3, 1999
Multicompartment analysis of gadolinium chelate kinetics: blood-tissue exchange in mammary tumors as monitored by dynamic MR imagingR E Port, M V Knopp, U Hoffmann, et al.
Pageof 5

Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 15, 2012
18F-FDG PET as a surrogate biomarker in non-small cell lung cancer treated with erlotinib: newly identified lesions are more informative than standardized uptake valueThomas Bengtsson, Rodney J Hicks, Amy Peterson, et al.
Oncology|November 1, 1994
Influence of tetrachlorodecaoxide (Ryoxon) on the development of leukemia after total-body gamma-irradiationS R Kempf, K Blaszkiewitz, R E Port, et al.
American Journal of Medical Genetics. Part A|November 24, 2004
Changing profile of couples seeking genetic counseling for consanguinity in AustraliaKatrina E Port, Helen Mountain, John Nelson, et al.
EJNMMI Research|February 3, 2012
Quantitation of glucose uptake in tumors by dynamic FDG-PET has less glucose bias and lower variability when adjusted for partial saturation of glucose transportSimon-Peter Williams, Judith E Flores-Mercado, Ruediger E Port, et al.
The British Journal of Surgery|August 12, 2008
Study of quadrant high-dose intraoperative radiation therapy for early-stage breast cancerV Sacchini, K Beal, J Goldberg, et al.
Cancer Research|March 15, 1988
Metabolites of 5-fluorouracil in plasma and urine, as monitored by 19F nuclear magnetic resonance spectroscopy, for patients receiving chemotherapy with or without methotrexate pretreatmentW E Hull, R E Port, R Herrmann, et al.
Clinical Pharmacology and Therapeutics|March 1, 1995
A population model for the leukopenic effect of etoposideM O Karlsson, R E Port, M J Ratain, et al.
Journal of Magnetic Resonance (San Diego, Calif. : 1997)|July 9, 1998
Monitoring local disposition kinetics of carboplatin in vivo after subcutaneous injection in rats by means of 195Pt NMRM Becker, R E Port, H J Zabel, et al.
Clinical Pharmacokinetics|January 13, 2004
Recombinant human erythropoietin for the treatment of renal anaemia in children: no justification for bodyweight-adjusted dosageRuediger E Port, Daniela Kiepe, Michael Van Guilder, et al.
Journal of Magnetic Resonance Imaging : JMRI|October 3, 1999
Multicompartment analysis of gadolinium chelate kinetics: blood-tissue exchange in mammary tumors as monitored by dynamic MR imagingR E Port, M V Knopp, U Hoffmann, et al.
Pageof 5